2.19
4.29%
+0.09
After Hours:
2.19
MyMD Pharmaceuticals Inc Stock (MYMD) Forecast
The MyMD Pharmaceuticals Inc (MYMD) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.9645, representing a +126.69% increase from the current price of $2.19. The highest analyst price target is $5.9939, and the lowest is $3.9352.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MYMD Price Target
Average 3.844
(+75.52% Upside)
Is MyMD Pharmaceuticals Inc (MYMD) A Buy Now?
Oscillators
Name | Value | Action |
---|---|---|
RSI(14) | 37.80 | Neutral |
STOCH(9,6) | 2.2956 | Buy |
STOCHRSI(14) | 9.1872 | Buy |
MACD(12,26) | -0.078 | Sell |
ADX(14) | 26.17 | Sell |
William %R | -92.90 | Buy |
CCI(14) | -123.05 | Sell |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
Period | Simple | Exponential |
---|---|---|
MA10 |
2.6001
Sell
|
2.4891
Sell
|
MA20 |
2.729
Sell
|
2.5954
Sell
|
MA50 |
2.6684
Sell
|
2.4877
Sell
|
MA100 |
1.8692
Buy
|
2.0786
Buy
|
MA200 |
1.238
Buy
|
1.726
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, MYMD could be considered a Strong Sell, with 17 technical analysis indicators signaling 7 Buy signals, 9 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on MYMD, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 37.8 indicates that MYMD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 2.2956 indicates that MYMD is oversold. This indicates that MYMD price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 9.1872 indicates that MYMD is oversold. This suggests that MYMD price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.17 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -123.05 indicates that MYMD is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term MYMD price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about MyMD Pharmaceuticals Inc financial reports and earnings history, MyMD Pharmaceuticals Inc (MYMD) stock could reach $2.7396 by 2030, $8.70 by 2040 and $15.69 by 2050. See the projected annual prices until 2050 of the MyMD Pharmaceuticals Inc stock below:
- MyMD Pharmaceuticals Inc (MYMD) is expected to reach an average price of $5.2841 in 2035, with a high prediction of $5.0941 and a low estimate of $4.7293. This indicates an $141.28% rise from the last recorded price of $2.19.
- MyMD Pharmaceuticals Inc (MYMD) stock is projected to chart a bullish course in 2040, with an average price target of $8.80, representing an $301.83% surge from its current level. The forecast ranges from a conservative $3.8485 to a sky-high $8.70.
- Our analysts predict MyMD Pharmaceuticals Inc (MYMD) to jump 403.26% by 2045, soaring from $10.72 to an average price of $11.02, potentially reaching $10.65. While $10.72 is the low estimate, the potential upside is significant.
- MyMD Pharmaceuticals Inc (MYMD) stock is expected to climb by 2050, reaching an average of $15.44, a $604.87% jump from its current level. However, a wide range of estimates exists, with high and low targets of $15.69 and $15.91, respectively, highlighting the market's uncertainty.
MyMD Pharmaceuticals Inc Stock (MYMD) Year by Year Forecast
MyMD Pharmaceuticals Inc Stock (MYMD) Price Forecast for 2024
Our forecast for MYMD stock price in 2024 now indicates an average price target of $3.8729 with a high forecast of $7.6378 and a low forecast of $0.108. The average prediction reflects an increase of +76.84% from the last recorded price of $2.19.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
June, 2024 | $5.3639 | $3.9352 | $5.9939 | +144.93% |
July, 2024 | $6.4353 | $4.5027 | $6.8253 | +193.85% |
August, 2024 | $4.1003 | $3.9103 | $7.6378 | +87.23% |
September, 2024 | $4.7954 | $3.4266 | $5.8792 | +118.97% |
October, 2024 | $2.6168 | $2.3268 | $4.7317 | +19.49% |
November, 2024 | $2.1419 | $1.5593 | $2.8631 | -2.20% |
December, 2024 | $1.797 | $1.3207 | $2.8944 | -17.95% |
MyMD Pharmaceuticals Inc Stock (MYMD) Price Forecast for 2025
MyMD Pharmaceuticals Inc Stock (MYMD) is expected to reach an average price of $2.0765 in 2025, with a high prediction of $4.1263 and a low estimate of $0.0267. This indicates an -5.18% fall from the last recorded price of $2.19.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2025 | $2.4983 | $1.0695 | $2.5883 | +14.08% |
February, 2025 | $1.5334 | $1.4434 | $2.7008 | -29.98% |
March, 2025 | $0.4885 | $0.0785 | $1.7447 | -77.69% |
April, 2025 | $0.2299 | $0.0501 | $1.226 | -89.50% |
May, 2025 | $2.1949 | $0.0676 | $2.3149 | +0.23% |
June, 2025 | $2.60 | $1.3438 | $2.9512 | +18.72% |
July, 2025 | $1.3414 | $1.0489 | $4.1263 | -38.75% |
August, 2025 | $0.6365 | $0.1503 | $1.8839 | -70.94% |
September, 2025 | $0.8816 | $0.1891 | $1.3328 | -59.75% |
October, 2025 | $0.3229 | $0.0267 | $0.9278 | -85.25% |
November, 2025 | $0.602 | $0.0455 | $0.3892 | -72.51% |
December, 2025 | $0.1306 | $0.3106 | $0.6694 | -94.04% |
MyMD Pharmaceuticals Inc Stock (MYMD) Price Forecast for 2026
The predicted value for MyMD Pharmaceuticals Inc (MYMD) in 2026 is set at an average of $0.6302. Estimates vary from a peak of $1.2535 to a trough of $0.007, indicating an -71.22% surge from the present price of $2.19.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2026 | $0.1245 | $0.0945 | $1.1377 | -94.32% |
February, 2026 | $0.1995 | $0.007 | $0.5807 | -90.89% |
March, 2026 | $0.0654 | $0.1058 | $0.5458 | -97.02% |
April, 2026 | $0.074 | $0.174 | $0.246 | -96.62% |
May, 2026 | $0.0111 | $0.0389 | $0.6148 | -99.49% |
June, 2026 | $0.0938 | $0.1488 | $0.129 | -95.72% |
July, 2026 | $0.5725 | $0.2376 | $0.4987 | -73.86% |
August, 2026 | $0.5274 | $0.2799 | $0.4701 | -75.92% |
September, 2026 | $1.0032 | $0.6311 | $0.8219 | -54.19% |
October, 2026 | $1.1685 | $1.1207 | $1.1259 | -46.64% |
November, 2026 | $1.1759 | $1.187 | $1.1421 | -46.31% |
December, 2026 | $1.2545 | $1.2446 | $1.2535 | -42.72% |
MyMD Pharmaceuticals Inc Stock (MYMD) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for MyMD Pharmaceuticals Inc (MYMD) is $2.7046, with a high forecast of $5.3256 and a low forecast of $0.0836. This indicates an +23.50% increase from the last price of $2.19.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2027 | $1.2507 | $1.2794 | $1.2712 | -42.89% |
February, 2027 | $1.3276 | $1.3059 | $1.2875 | -39.38% |
March, 2027 | $1.927 | $1.328 | $2.387 | -12.01% |
April, 2027 | $1.4521 | $1.4521 | $2.172 | -33.69% |
May, 2027 | $0.9972 | $0.6609 | $2.0972 | -54.47% |
June, 2027 | $0.80 | $0.252 | $1.9823 | -63.47% |
July, 2027 | $2.0002 | $0.2125 | $2.0602 | -8.67% |
August, 2027 | $2.5103 | $1.8127 | $3.6378 | +14.63% |
September, 2027 | $4.9131 | $2.1654 | $5.0131 | +124.34% |
October, 2027 | $3.0532 | $1.1332 | $5.3256 | +39.42% |
November, 2027 | $1.9134 | $1.7109 | $3.5983 | -12.63% |
December, 2027 | $0.4639 | $0.0836 | $2.2785 | -78.82% |
MyMD Pharmaceuticals Inc Stock (MYMD) Price Forecast for 2028
In 2028, MyMD Pharmaceuticals Inc (MYMD) is projected to reach an average price of $1.1038, with a high projection of $2.1026 and a low estimate of $0.105. This indicates an -49.60% fall from the last price of $2.19.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2028 | $0.0463 | $0.3862 | $0.2663 | -97.89% |
February, 2028 | $0.6935 | $0.2411 | $0.6889 | -68.33% |
March, 2028 | $0.4092 | $0.2704 | $0.641 | -81.32% |
April, 2028 | $0.5206 | $0.4783 | $0.5516 | -76.23% |
May, 2028 | $1.1879 | $1.1481 | $1.253 | -45.76% |
June, 2028 | $2.0977 | $1.2654 | $1.7277 | -4.21% |
July, 2028 | $0.00244 | $0.1818 | $1.7552 | -99.89% |
August, 2028 | $0.5948 | $0.105 | $2.1026 | -72.84% |
September, 2028 | $0.3947 | $0.7447 | $0.2972 | -81.98% |
October, 2028 | $1.1845 | $0.8521 | $1.147 | -45.91% |
November, 2028 | $1.4418 | $1.209 | $1.182 | -34.17% |
December, 2028 | $1.6816 | $1.7641 | $1.5967 | -23.21% |
MyMD Pharmaceuticals Inc Stock (MYMD) Price Forecast for 2029
The 2029 price forecast for MyMD Pharmaceuticals Inc Stock (MYMD) is $1.9503 on average, with a high prediction of $2.7169 and a low estimate of $1.1836. This represents an -10.95% decrease from the previous price of $2.19.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2029 | $2.6089 | $1.8591 | $2.5489 | +19.13% |
February, 2029 | $2.0787 | $2.1713 | $2.4663 | -5.08% |
March, 2029 | $1.6085 | $1.1836 | $1.2485 | -26.55% |
April, 2029 | $1.5684 | $1.6984 | $1.6009 | -28.39% |
May, 2029 | $2.0056 | $1.9158 | $1.7932 | -8.42% |
June, 2029 | $1.6955 | $1.8255 | $1.8233 | -22.58% |
July, 2029 | $1.6353 | $1.5004 | $1.6353 | -25.33% |
August, 2029 | $2.2226 | $1.8527 | $1.8426 | +1.49% |
September, 2029 | $1.8824 | $2.1924 | $2.18 | -14.05% |
October, 2029 | $2.3182 | $1.9399 | $2.1797 | +5.85% |
November, 2029 | $2.6595 | $2.3871 | $2.5795 | +21.44% |
December, 2029 | $2.7622 | $2.7242 | $2.7169 | +26.13% |
MyMD Pharmaceuticals Inc Stock (MYMD) Price Forecast for 2030
MyMD Pharmaceuticals Inc Stock (MYMD) is expected to reach an average price of $1.5152 in 2030, with a high forecast of $3.0134 and a low forecast of $0.017. This signifies an -30.81% decrease from the last price of $2.19.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2030 | $2.8166 | $2.7592 | $2.7396 | +28.61% |
February, 2030 | $2.7964 | $2.8088 | $2.788 | +27.69% |
March, 2030 | $2.7963 | $2.7888 | $2.7869 | +27.68% |
April, 2030 | $2.8061 | $2.8027 | $2.7798 | +28.13% |
May, 2030 | $0.5366 | $0.1461 | $2.7859 | -75.50% |
June, 2030 | $0.1932 | $0.0243 | $0.7442 | -91.18% |
July, 2030 | $0.0595 | $0.2805 | $0.6944 | -97.28% |
August, 2030 | $1.8012 | $0.0271 | $1.50 | -17.75% |
September, 2030 | $0.6341 | $0.5559 | $1.1624 | -71.05% |
October, 2030 | $0.0218 | $0.0207 | $1.2817 | -99.00% |
November, 2030 | $1.6934 | $0.017 | $3.0134 | -22.68% |
December, 2030 | $0.7987 | $0.4687 | $2.3493 | -63.53% |
Cap:
|
Volume (24h):